Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q43053015)
Watch
English
Reporting of adjuvant breast cancer trials: when is the right time?
scientific article published on 21 November 2011
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
editorial
0 references
title
Reporting of adjuvant breast cancer trials: when is the right time?
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
author
Helena Earl
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
author name string
Helena M Earl
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
retrieved
13 November 2017
language of work or name
English
0 references
publication date
21 November 2011
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
published in
Journal of Clinical Oncology
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
volume
30
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
page(s)
1-2
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
cites work
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255558
retrieved
26 May 2018
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255558
retrieved
26 May 2018
Cautionary tales of survival analysis: conflicting analyses from a clinical trial in breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255558
retrieved
26 May 2018
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255558
retrieved
16 August 2018
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255558
retrieved
16 August 2018
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255558
retrieved
1 December 2018
Identifiers
DOI
10.1200/JCO.2011.38.2747
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
PMC publication ID
3255558
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
PubMed publication ID
22105825
1 reference
stated in
Europe PubMed Central
PMC publication ID
3255558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22105825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
